Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Svend Strandgaard

Showing results (31-40 of 39) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 39 results.
American Journal of Nephrology|July 11, 2006
Flow-associated dilatory capacity of the brachial artery is intact in early autosomal dominant polycystic kidney diseasePeter Clausen, Bo Feldt-Rasmussen, Jens Iversen, et al.
Plos One|August 4, 2012
Beneficial effects on arterial stiffness and pulse-wave reflection of combined enalapril and candesartan in chronic kidney disease--a randomized trialMarie Frimodt-Møller, Anne-Lise Kamper, Svend Strandgaard, et al.
Plos One|November 11, 2011
Moderate antiproteinuric effect of add-on aldosterone blockade with eplerenone in non-diabetic chronic kidney disease. A randomized cross-over studyLene Boesby, Thomas Elung-Jensen, Tobias Wirenfeldt Klausen, et al.
Journal of the Renin-Angiotensin-Aldosterone System : JRAAS|March 11, 2020
No effect of the angiotensin receptor blocker candesartan on cerebrovascular autoregulation in rats during very high and low sodium intakeSigurdur T Sigurdsson, Peter Bie, Arne H Nielsen, et al.
American Journal of Nephrology|November 6, 2009
Estimating glomerular filtration rate using the new CKD-EPI equation and other equations in patients with autosomal dominant polycystic kidney diseaseBjarne Orskov, Malene L Borresen, Bo Feldt-Rasmussen, et al.
Ugeskrift for Laeger|October 5, 2002
[Microalbuminuria is associated with a fourfold increased risk of ischemic heart disease among hypertensive patients]Jan Skov Jensen, Bo F Feldt-Rasmussen, Svend Strandgaard, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|January 25, 2008
Asymmetric dimethylarginine and lipid peroxidation products in early autosomal dominant polycystic kidney diseaseDan Wang, Svend Strandgaard, Malene L Borresen, et al.
Kidney International|December 22, 2004
The effect of angiotensin-converting-enzyme inhibitors on progression of advanced polycystic kidney diseaseTazeen H Jafar, Paul C Stark, Christopher H Schmid, et al.
Expert Review of Neurotherapeutics|September 23, 2009
Angiotensin AT1-receptor blockers and cerebrovascular protection: do they actually have a cutting edge over angiotensin-converting enzyme inhibitors?Roxana Oprisiu-Fournier, Sébastien Faure, Hakim Mazouz, et al.
Pageof 4

Showing results (31-40 of 39) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 39 results.
American Journal of Nephrology|July 11, 2006
Flow-associated dilatory capacity of the brachial artery is intact in early autosomal dominant polycystic kidney diseasePeter Clausen, Bo Feldt-Rasmussen, Jens Iversen, et al.
Plos One|August 4, 2012
Beneficial effects on arterial stiffness and pulse-wave reflection of combined enalapril and candesartan in chronic kidney disease--a randomized trialMarie Frimodt-Møller, Anne-Lise Kamper, Svend Strandgaard, et al.
Plos One|November 11, 2011
Moderate antiproteinuric effect of add-on aldosterone blockade with eplerenone in non-diabetic chronic kidney disease. A randomized cross-over studyLene Boesby, Thomas Elung-Jensen, Tobias Wirenfeldt Klausen, et al.
Journal of the Renin-Angiotensin-Aldosterone System : JRAAS|March 11, 2020
No effect of the angiotensin receptor blocker candesartan on cerebrovascular autoregulation in rats during very high and low sodium intakeSigurdur T Sigurdsson, Peter Bie, Arne H Nielsen, et al.
American Journal of Nephrology|November 6, 2009
Estimating glomerular filtration rate using the new CKD-EPI equation and other equations in patients with autosomal dominant polycystic kidney diseaseBjarne Orskov, Malene L Borresen, Bo Feldt-Rasmussen, et al.
Ugeskrift for Laeger|October 5, 2002
[Microalbuminuria is associated with a fourfold increased risk of ischemic heart disease among hypertensive patients]Jan Skov Jensen, Bo F Feldt-Rasmussen, Svend Strandgaard, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|January 25, 2008
Asymmetric dimethylarginine and lipid peroxidation products in early autosomal dominant polycystic kidney diseaseDan Wang, Svend Strandgaard, Malene L Borresen, et al.
Kidney International|December 22, 2004
The effect of angiotensin-converting-enzyme inhibitors on progression of advanced polycystic kidney diseaseTazeen H Jafar, Paul C Stark, Christopher H Schmid, et al.
Expert Review of Neurotherapeutics|September 23, 2009
Angiotensin AT1-receptor blockers and cerebrovascular protection: do they actually have a cutting edge over angiotensin-converting enzyme inhibitors?Roxana Oprisiu-Fournier, Sébastien Faure, Hakim Mazouz, et al.
Pageof 4